Investigating how Chlamydia pneumoniae infects human cells
Addressing genetic tractability and species-specific infection biology in Chlamydia pneumoniae
['FUNDING_R21'] · UNIVERSITY OF KENTUCKY · NIH-10735892
This study is looking at how the Chlamydia pneumoniae bacteria cause respiratory infections, like pneumonia and bronchitis, by using new tools to change its genes, which could help us find better treatments for these illnesses.
Quick facts
| Phase | ['FUNDING_R21'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF KENTUCKY (nih funded) |
| Locations | 1 site (LEXINGTON, UNITED STATES) |
| Trial ID | NIH-10735892 on ClinicalTrials.gov |
What this research studies
This research focuses on understanding the infection mechanisms of Chlamydia pneumoniae, a common respiratory pathogen. By developing new genetic tools, the researchers aim to manipulate the bacteria's genes to better understand how it interacts with human cells. This could lead to insights into the disease processes associated with infections like pneumonia and bronchitis. The study will also explore the differences between Chlamydia pneumoniae and other related species, which may help in developing targeted treatments.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals experiencing respiratory infections, particularly those diagnosed with pneumonia or bronchitis.
Not a fit: Patients with infections caused by other pathogens unrelated to Chlamydia pneumoniae may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatments for respiratory infections caused by Chlamydia pneumoniae.
How similar studies have performed: While research on Chlamydia trachomatis has shown success in understanding its infection mechanisms, this approach for Chlamydia pneumoniae is relatively novel and untested.
Where this research is happening
LEXINGTON, UNITED STATES
- UNIVERSITY OF KENTUCKY — LEXINGTON, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: FIELDS, KENNETH A — UNIVERSITY OF KENTUCKY
- Study coordinator: FIELDS, KENNETH A
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.